Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Justin Iorio

Orthopaedic Surgery of the Spine Syracuse, NY Medical Doctor

NPI 1225359532 CMS profile 9967

5719 Widewaters Pkwy, Syracuse, NY 13214

Open in the dashboard

General payments

$119,350

79 records reported · program years 2019–2025

Research payments

$3,000

Paid to them · 10 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Justin Iorio of Syracuse, NY is reported in the CMS Open Payments database as having received $119,350 across 79 general payments and $3,000 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $54,295 15
2024 General $27,731 9
2024 Research $3,000 10
2023 General $5,248 8
2022 General $1,000 1
2021 General $9,078 20
2020 General $10,759 15
2019 General $11,239 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Justin Iorio
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Justin Iorio were reported at $54,295. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Justin Iorio Orthopaedic Surgery of the Spine median Middle half National median
2019 $11,239 $2,106 $337–$18,608 $163
2020 $10,759 $1,213 $156–$15,082 $114
2021 $9,078 $1,834 $271–$15,617 $132
2022 $1,000 $2,015 $320–$17,036 $149
2023 $5,248 $1,925 $336–$14,599 $160
2024 $27,731 $2,110 $341–$12,483 $164
2025 $54,295 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. SurGenTec $62,176 9 payments
  2. Spine Wave, Inc. $24,910 18 payments
  3. Medicrea USA, Corp. $17,226 8 payments
  4. Alphatec Spine, Inc $6,922 26 payments
  5. TrackX Technology, LLC $6,742 3 payments
  6. Zimvie Inc. $927 4 payments
  7. Intrinsic Therapeutics $166 4 payments
  8. Ethicon US, LLC $113 1 payment
  9. Medtronic, Inc. $100 2 payments
  10. Aesculap, Inc. $24 1 payment
  11. Other $43 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $86,904 13 payments
  2. Consulting Fee $19,025 14 payments
  3. Travel and Lodging $8,353 24 payments
  4. Food and Beverage $3,180 23 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,699 1 payment
  6. Entertainment $188 4 payments
Products named General payments · program years 2019–2025
  1. Osteoflo $29,291 2 payments
  2. Hydroputty $27,561 1 payment
  3. EXCEED BIPLANAR EXPANDABLE INTERBODY SYSTEM $15,327 3 payments
  4. PASS-LP $9,715 4 payments
  5. UNiD $9,715 4 payments
  6. PASS LP $7,511 4 payments
  7. Other - Miscellaneous $5,651 14 payments
  8. Hydrofiber Device $2,625 4 payments
  9. Hydrofiber Device $1,699 1 payment
  10. Spinal Implants $1,498 5 payments
  11. Other $2,207 27 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Intrinsic Therapeutics $3,000 10 payments

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

381

Median for Orthopedic Surgery: 203

Drug cost

$2,052

Median for Orthopedic Surgery: $1,433

Branded share of claims

2.9%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 63 $501
Celecoxib Generic 27 $312
Methylprednisolone Generic 51 $293
Diclofenac Sodium Generic 18 $192
Oxycodone Hcl Generic 35 $154
Meloxicam Generic 73 $144
Mupirocin Generic 19 $128
Naproxen Generic 16 $92
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 11 $77
Ciprofloxacin Hcl Generic 11 $68

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 73 billing codes

Paid by Medicare

$207,120

Medicare's payments for the services billed

Medicare patients

302

Average age 72

Services billed

1,101

154 women, 148 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 74%
High blood pressure 73%
Diabetes 24%
Ischemic heart disease 23%
Depression 23%
Chronic kidney disease 20%
Cancer 18%
COPD 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

89 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record